Can B (OTC: CANB)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Can B (OTCQB: CANB) through any online brokerage.
There are no as such competitors for Can B.
The latest price target for Can B (OTCQB: CANB) was reported by Greenridge Global on Tuesday, October 26, 2021. The analyst firm set a price target for 1.20 expecting CANB to fall to within 12 months (a possible -72.09% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Can B (OTCQB: CANB) is $4.3 last updated July 5, 2022, 7:56 PM UTC.
There are no upcoming dividends for Can B.
Can B does not have any upcoming earnings scheduled.
There is no upcoming split for Can B.
Can B is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.